Motixafortide price?

There isn’t a publicly listed price for Motixafortide (also known as BL-8040) because it is not approved for commercial use in the US or EU. Pricing for drugs in development isn’t disclosed in the same way as approved medicines, and any cost would depend on trial agreements or future reimbursement decisions.

If you’re a patient or clinician:
- For trial-related costs, contact the sponsor or the clinical trial site.
- If you meant a different drug (for example, plerixafor, sold as Mozobil, used for stem-cell mobilization), I can share typical price ranges or help compare options by country.

If you’d like, I can look up the latest regulatory status and any public updates on Motixafortide’s development and potential pricing once you specify your region.